Clinical Rheumatology

, Volume 27, Issue 1, pp 35–39

Adult onset Still’s disease: a study of 14 cases

Original Article


We studied the clinical profile, laboratory parameters, disease course, and outcomes of patients with adult onset Still’s disease (AOSD). A retrospective analysis of adult patients with Still’s disease diagnosed from 2000 to 2004 was carried out. Their clinical features and laboratory findings at presentation, disease course, and outcomes were analyzed. Data of 14 patients with Still’s disease were analyzed. The age at disease onset ranged from 16 to 59 years with a mean of 29.85, the male to female ratio being 9:5. The mean duration of illness from onset of symptoms to presentation was 14.5 months (range). The most common clinical manifestations were fever (n = 14), articular symptoms (n = 14), rash (n = 8), weight loss (n = 12), and sore throat (n = 5). Elevated ESR was present in all patients with a mean of 98.3 mm at 1 h. Hepatic enzymes were elevated in seven patients at disease onset. The mean duration of follow up was 19.14 months (range). Three patients progressed to chronic arthropathy. Cyclosporine led to dramatic recovery in five patients. Macrophage activation syndrome (MAS) was present in two patients, one after sulfasalazine therapy. One patient with MAS died. Still’s disease, although uncommon, has characteristic constellation of clinical and laboratory features and should be considered in the differential diagnosis of fever of unknown origin. Nonsteroidal anti-inflammatory drugs, steroids, and methotrexate may not be always effective, and cyclosporine is an effective drug in resistant cases. Sulfasalazine should be avoided in cases of AOSD.


Adult onset Still’s disease Arthropathy Cyclosporine Macrophage activation syndrome Sulfasalazine 


  1. 1.
    Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMedGoogle Scholar
  2. 2.
    Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30(2):121–133PubMedGoogle Scholar
  3. 3.
    Larson EB (1984) Adult Still’s disease: evolution of clinical syndrome and diagnosis, treatment and follow up of 17 patients. Medicine (Baltimore) 63:82–91Google Scholar
  4. 4.
    Singh YN, Adya CM, Kumar A, Malaviya AN (1992) Adult-onset Still’s disease. Br J Rheumatol 31(6):417–419CrossRefPubMedGoogle Scholar
  5. 5.
    Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD (1992) Adult onset Still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 51(4):529–532PubMedCrossRefGoogle Scholar
  6. 6.
    Goldman JA, Board MR, Casey HL (1980) Acute febrile juvenile rheumatoid arthritis in adults: cause of polyarthritis and fever. South Med J 73:555–563PubMedGoogle Scholar
  7. 7.
    Medsger TA Jr, Christy WC (1976) Carpal arthritis with ankylosis in late onset Still’s disease. Arthritis Rheum 19(2):232–242CrossRefPubMedGoogle Scholar
  8. 8.
    Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552CrossRefPubMedGoogle Scholar
  9. 9.
    Baker DG, Schumaker HR, Reginato AJ (1979) Fifteen patients with adult onset Still’s disease. Life threatening liver failure in two (abstract). Arthritis Rheum 22:590Google Scholar
  10. 10.
    Tesser JRP, Pisko EJ, Hartz JW, Weinblatt ME (1982) Chronic liver disease and adult onset Still’s disease. Arthritis Rheum 25:579–583CrossRefPubMedGoogle Scholar
  11. 11.
    Olive A, Junca J, Tena X (1991) Ferritin and adult Still’s disease. Br J Rheumatol 30(2):158CrossRefPubMedGoogle Scholar
  12. 12.
    Ota T, Higashi S, Suzuki H, Eto S (1987) Increased serum ferritin levels in adult Still’s disease. Lancet 1(8532):562–563CrossRefPubMedGoogle Scholar
  13. 13.
    Hamidou MA, Denis M, Barbarot S, Boutoille D, Belizna C, Le Moel G (2004) Usefulness of glycosylated ferritin in atypical presentations of adult onset Still’s disease. Ann Rheum Dis 63(5):605 (May)CrossRefPubMedGoogle Scholar
  14. 14.
    Pouchot J, Vinceneux P (2004) Diagnosis, progression and prognosis, aetiology and treatment of adult-onset Still’s disease. Presse Med 33(15):1019–1026 (Sep 11)PubMedGoogle Scholar
  15. 15.
    Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F (1997) Cyclosporin A in the treatment of adult onset Still’s disease. J Rheumatol 24(8):1582–1587PubMedGoogle Scholar
  16. 16.
    Crowley J, Situnayake RD (1992) Sulphasalazine induced hepatitis in adult Still’s disease. Ann Rheum Dis 51(11):1264–1265PubMedGoogle Scholar
  17. 17.
    Jung JH, Jun JB, Yoo DH et al (2000) High toxicity of sulfasalazine in adult onset Still’s disease. Clin Exp Rheumatol 18:245–248PubMedGoogle Scholar
  18. 18.
    Chen DY, Lan JL, Hsieh TY, Chen YH (2004) Clinical manifestations, disease course, and complications of adult-onset Still’s disease in Taiwan. J Formos Med Assoc 103(11):844–852PubMedGoogle Scholar
  19. 19.
    Mert A, Ozras R, Tabak F, Bilir M, Ozturk R, Ozdogan H, Aktuglu Y (2003) Fever of unknown origin: a review of 20 patients with adult onset Still’s disease. Clin Rheumatol 22(2):89–93CrossRefPubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2007

Authors and Affiliations

  1. 1.Department of RheumatologyP.D. Hinduja National Hospital & Medical Research CenterMumbai-16India

Personalised recommendations